{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T20:54:08Z","timestamp":1782852848275,"version":"3.54.5"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T00:00:00Z","timestamp":1624406400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>The purpose of this study was to evaluate the efficacy of topical ivermectin 1% cream application on the eyelashes in combination with eyelid hygiene in the treatment of Demodex blepharitis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>One hundred two eyes of 102 patients with symptomatic Demodex blepharitis were divided into 2 groups according to the use of topical ivermectin in this retrospective case\u2013control study. The ivermectin group (n = 51) applied topical ivermectin 1% cream on the eyelashes for 15 minutes once weekly, but the control group (n = 51) did not. In both groups, eyelid hygiene was performed once daily. The Standard Patient Evaluation of Eye Dryness (SPEED) symptom questionnaire score, Oxford staining score, eyelid debris, eyelid redness\/swelling, and telangiectasia were assessed during the follow-up visits.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The mean follow-up periods of the ivermectin and control groups were 15.1 \u00b1 9.7 weeks and 14.8 \u00b1 8.6 weeks, respectively. The SPEED score and eyelid debris grade were significantly improved in both groups during the follow-up, although the SPEED score and eyelid debris grade showed greater changes in the ivermectin group than in the control group. The Oxford staining score, eyelid redness\/swelling grade, and telangiectasia grade were significantly improved only in the ivermectin group but not in the control group.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>In patients with Demodex blepharitis, the use of topical ivermectin 1% cream for 15 minutes once weekly in addition to eyelid hygiene had more significantly improved symptoms, ocular surface staining, eyelid debris, redness\/swelling, and telangiectasia as compared with eyelid hygiene alone. These findings support the efficacy of topical ivermectin 1% cream application in the treatment of Demodex blepharitis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ico.0000000000002802","type":"journal-article","created":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T06:00:16Z","timestamp":1624687216000},"page":"427-434","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":32,"title":["Efficacy of Topical Ivermectin 1% in the Treatment of Demodex Blepharitis"],"prefix":"10.1097","volume":"41","author":[{"given":"Young","family":"Choi","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Korea University College of Medicine, Seoul, Republic of Korea;"},{"name":"Department of Ophthalmology, Korea University Ansan Hospital, Gyeonggi-do, Republic of Korea;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9475-4409","authenticated-orcid":false,"given":"Youngsub","family":"Eom","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Korea University College of Medicine, Seoul, Republic of Korea;"},{"name":"Department of Ophthalmology, Korea University Ansan Hospital, Gyeonggi-do, Republic of Korea;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Gyu","family":"Yoon","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Korea University College of Medicine, Seoul, Republic of Korea;"},{"name":"Department of Ophthalmology, Korea University Ansan Hospital, Gyeonggi-do, Republic of Korea;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Suk","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Korea University College of Medicine, Seoul, Republic of Korea;"},{"name":"Department of Ophthalmology, Korea University Guro Hospital, Seoul, Republic of Korea;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Il-Hwan","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Korea University College of Medicine, Seoul, Republic of Korea; and"},{"name":"Department of Dermatology, Korea University Ansan Hospital, Gyeonggi-do, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo Myung","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Korea University College of Medicine, Seoul, Republic of Korea;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,6,23]]},"reference":[{"key":"R1-20250728","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0738-081X(01)00244-9","article-title":"Demodex folliculorum in development of dermatitis rosaceiformis steroidica and rosacea-related diseases","volume":"20","author":"Basta-Juzbasi\u0107","year":"2002","journal-title":"Clin Dermatol."},{"key":"R2-20250728","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/0002-9394(81)90291-9","article-title":"Demodicosis of ophthalmic concern","volume":"91","author":"English","year":"1981","journal-title":"Am J Ophthalmol."},{"key":"R3-20250728","first-page":"361","article-title":"Demodex folliculorum blepharitis","volume":"65","author":"Coston","year":"1967","journal-title":"Trans Am Ophthalmol Soc."},{"key":"R4-20250728","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1346-8138.2004.tb00567.x","article-title":"The clinical importance of Demodex folliculorum presenting with nonspecific facial signs and symptoms","volume":"31","author":"Karincaoglu","year":"2004","journal-title":"J Dermatol."},{"key":"R5-20250728","first-page":"525","article-title":"Blepharitis due to Demodex: myth or reality? [in French]","volume":"22","author":"Kamoun","year":"1999","journal-title":"J Fr Ophtalmol."},{"key":"R6-20250728","first-page":"127","article-title":"Demodex folliculorum and Demodex brevis (Acarida) as the factors of chronic marginal blepharitis [in Polish]","volume":"37","author":"Humiczewska","year":"1991","journal-title":"Wiad Parazytol."},{"key":"R7-20250728","first-page":"914","article-title":"Clinical manifestations of demodicosis","volume":"57","author":"Heacock","year":"1986","journal-title":"J Am Optom Assoc."},{"key":"R8-20250728","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/01.ico.0000244870.62384.79","article-title":"Clinical treatment of ocular demodicosis by lid scrub with tea tree oil","volume":"26","author":"Gao","year":"2007","journal-title":"Cornea."},{"key":"R9-20250728","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.3346\/jkms.2012.27.12.1574","article-title":"Ocular surface discomfort and Demodex: effect of tea tree oil eyelid scrub in Demodex blepharitis","volume":"27","author":"Koo","year":"2012","journal-title":"J Korean Med Sci."},{"key":"R10-20250728","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1113\/JP275236","article-title":"Ivermectin and its target molecules: shared and unique modulation mechanisms of ion channels and receptors by ivermectin","volume":"596","author":"Chen","year":"2018","journal-title":"J Physiol."},{"key":"R11-20250728","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1136\/bjo.2010.201194","article-title":"The efficacy of oral ivermectin for the treatment of chronic blepharitis in patients tested positive for Demodex spp","volume":"95","author":"Filho","year":"2011","journal-title":"Br J Ophthalmol."},{"key":"R12-20250728","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.ajo.2010.11.024","article-title":"Clinical treatment of ocular Demodex folliculorum by systemic ivermectin","volume":"151","author":"Holzchuh","year":"2011","journal-title":"Am J Ophthalmol."},{"key":"R13-20250728","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jtos.2017.05.006","article-title":"TFOS DEWS II management and therapy report","volume":"15","author":"Jones","year":"2017","journal-title":"Ocul Surf."},{"key":"R14-20250728","doi-asserted-by":"crossref","first-page":"101326","DOI":"10.1016\/j.clae.2020.04.011","article-title":"Topical ivermectin-metronidazole gel therapy in the treatment of blepharitis caused by Demodex spp.: a randomized clinical trial","volume":"44","author":"\u00c1vila","year":"2021","journal-title":"Cont Lens Anterior Eye."},{"key":"R15-20250728","doi-asserted-by":"crossref","first-page":"e343","DOI":"10.1016\/j.ijid.2012.11.022","article-title":"Evaluation of the efficacy of oral ivermectin in comparison with ivermectin-metronidazole combined therapy in the treatment of ocular and skin lesions of Demodex folliculorum","volume":"17","author":"Salem","year":"2013","journal-title":"Int J Infect Dis."},{"key":"R16-20250728","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/ACI.0b013e32833df9f4","article-title":"Pathogenic role of Demodex mites in blepharitis","volume":"10","author":"Liu","year":"2010","journal-title":"Curr Opin Allergy Clin Immunol."},{"issue":"suppl 1","key":"R17-20250728","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1097\/ICO.0000000000001361","article-title":"Ocular demodicosis as a potential cause of ocular surface inflammation","volume":"36","author":"Luo","year":"2017","journal-title":"Cornea."},{"key":"R18-20250728","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1007\/s12325-008-0096-9","article-title":"Efficacy of topical azithromycin ophthalmic solution 1% in the treatment of posterior blepharitis","volume":"25","author":"Luchs","year":"2008","journal-title":"Adv Ther."},{"key":"R19-20250728","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1590\/S0004-27492012000300006","article-title":"Azithromycin 1.5% ophthalmic solution: efficacy and treatment modalities in chronic blepharitis","volume":"75","author":"Fadlallah","year":"2012","journal-title":"Arq Bras Oftalmol."},{"key":"R21-20250728","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ajo.2016.06.025","article-title":"Development of definitive and reliable grading scales for meibomian gland dysfunction","volume":"169","author":"Arita","year":"2016","journal-title":"Am J Ophthalmol."},{"key":"R22-20250728","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2147\/OPTO.S142708","article-title":"Demodex blepharitis: clinical perspectives","volume":"10","author":"Fromstein","year":"2018","journal-title":"Clin Optom (Auckl)."},{"key":"R23-20250728","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/0140-6736(90)91253-7","article-title":"Safety of and compliance with community-based ivermectin therapy","volume":"335","author":"Pacqu\u00e9","year":"1990","journal-title":"Lancet."},{"key":"R24-20250728","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0140-6736(96)11094-1","article-title":"Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection","volume":"350","author":"Gardon","year":"1997","journal-title":"Lancet."},{"key":"R25-20250728","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1017\/S003118202000150X","article-title":"Comparison of the efficacy of tea tree (Melaleuca alternifolia) oil with other current pharmacological management in human demodicosis: a systematic review","volume":"147","author":"Lam","year":"2020","journal-title":"Parasitology."},{"key":"R26-20250728","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1111\/bjd.13408","article-title":"Superiority of ivermectin 1% cream over metronidazole 0\u00b775% cream in treating inflammatory lesions of rosacea: a randomized, investigator-blinded trial","volume":"172","author":"Taieb","year":"2015","journal-title":"Br J Dermatol."},{"key":"R27-20250728","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1365-4632.2004.02253.x","article-title":"Ivermectin: pharmacology and application in dermatology","volume":"44","author":"Dourmishev","year":"2005","journal-title":"Int J Dermatol."},{"key":"R28-20250728","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1186\/1475-2875-11-381","article-title":"Ivermectin inhibits the sporogony of Plasmodium falciparum in Anopheles gambiae","volume":"11","author":"Kobylinski","year":"2012","journal-title":"Malar J."},{"key":"R29-20250728","doi-asserted-by":"crossref","first-page":"20187","DOI":"10.1074\/jbc.271.33.20187","article-title":"Identification of a Drosophila melanogaster glutamate-gated chloride channel sensitive to the antiparasitic agent avermectin","volume":"271","author":"Cully","year":"1996","journal-title":"J Biol Chem."},{"key":"R30-20250728","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1472-8206.2009.00684.x","article-title":"Avermectin exerts anti\u2010inflammatory effect by downregulating the nuclear transcription factor kappa\u2010B and mitogen\u2010activated protein kinase activation pathway","volume":"23","author":"Ci","year":"2009","journal-title":"Fundam Clin Pharmacol."},{"key":"R31-20250728","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1001\/archderm.1985.01660030027007","article-title":"Metronidazole in the treatment of rosacea","volume":"121","year":"1985","journal-title":"Arch Dermatol."},{"issue":"5 pt 2","key":"R32-20250728","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0190-9622(89)70107-9","article-title":"Unilateral demodectic rosacea","volume":"20","author":"Shelley","year":"1989","journal-title":"J Am Acad Dermatol."},{"key":"R33-20250728","first-page":"94","article-title":"Topical metronidazole: a new therapy for rosacea","volume":"9","author":"Schmadel","year":"1990","journal-title":"Clin Pharm."},{"key":"R34-20250728","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jtos.2019.06.004","article-title":"Efficacy of treatments for Demodex blepharitis: a systematic review and meta-analysis","volume":"17","author":"Navel","year":"2019","journal-title":"Ocul Surf."},{"key":"R35-20250728","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1645\/18-46","article-title":"Evaluation of the efficacy of tea tree oil on the density of Demodex mites (Acari: Demodicidae) and ocular symptoms in patients with demodectic blepharitis","volume":"104","author":"Karakurt","year":"2018","journal-title":"J Parasitol."},{"key":"R36-20250728","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.clae.2018.08.003","article-title":"In vitro anti-demodectic effects and terpinen-4-ol content of commercial eyelid cleansers","volume":"41","author":"Cheung","year":"2018","journal-title":"Cont Lens Anterior Eye."},{"key":"R37-20250728","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/mmy\/myu072","article-title":"In vitro activity of Melaleuca alternifolia (tea tree) oil on filamentous fungi and toxicity to human cells","volume":"53","author":"Homeyer","year":"2015","journal-title":"Med Mycol."},{"key":"R38-20250728","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/ICU.0000000000000168","article-title":"Recent advances on ocular Demodex infestation","volume":"26","author":"Cheng","year":"2015","journal-title":"Curr Opin Ophthalmol."}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ICO.0000000000002802","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T22:06:45Z","timestamp":1753740405000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/ICO.0000000000002802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,23]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0000000000002802","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6,23]]},"assertion":[{"value":"2021-01-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}